|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
JPRN |
|
Last refreshed on:
|
17 October 2023 |
|
Main ID: |
JPRN-UMIN000025703 |
|
Date of registration:
|
01/02/2017 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Effect of thiamine for the treatment of motor and non-motor symptom in hereditary neurological or neurodegenerative disorders
|
|
Scientific title:
|
Effect of thiamine for the treatment of motor and non-motor symptom in hereditary neurological or neurodegenerative disorders - Effect of thiamine for neurodegenerative disorders |
|
Date of first enrolment:
|
2017/01/16 |
|
Target sample size:
|
50 |
|
Recruitment status: |
Complete: follow-up complete |
|
URL:
|
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029572 |
|
Study type:
|
Interventional |
|
Study design:
|
Single arm Non-randomized
|
|
Phase:
|
Not applicable
|
|
|
Countries of recruitment
|
|
Japan
| | | | | | | |
|
Contacts
|
|
Name:
|
Noriyuki Miyaue |
|
Address:
|
454, shitsukawa Tohon, Ehime, Japan
Japan |
|
Telephone:
|
089-960-5095 |
|
Email:
|
miyaue@m.ehime-u.ac.jp |
|
Affiliation:
|
Ehime University Graduate School of Medicine Department of Neurology and Clinical Pharmacology |
|
|
Name:
|
Noriyuki Miyaue |
|
Address:
|
454, shitsukawa Tohon, Ehime, Japan
Japan |
|
Telephone:
|
089-960-5095 |
|
Email:
|
miyaue@m.ehime-u.ac.jp |
|
Affiliation:
|
Ehime University Graduate School of Medicine Department of Neurology and Clinical Pharmacology |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
Exclusion criteria: Patients disagreed to this study Who have been regarded to be inappropriate to participate in the study
Age minimum:
20years-old
Age maximum:
Not applicable
Gender:
Male and Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Parkinson's disease spinocerebellar ataxia
|
|
Intervention(s)
|
|
fursultiamine 100mg
|
|
Primary Outcome(s)
|
|
UPDRS, SARA, FSS, PFSI(before treatment and at 1, 3, 6 and 12 months after treatment)
|
|
Source(s) of Monetary Support
|
|
none
|
|
Ethics review
|
Status: YES
Approval date:
Contact:
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|